The effects of serine palmitoyltransferase inhibitor, ISP-I, on uv-induced barrier disruption in the stratum corneum

4Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

We examined the effects of ISP-I (myriocin, thermozymocidin)-a potent inhibitor of serine palmitoyltransferase (SPT) which is involved in the ceramide synthetic pathway-on skin barrier function in post-UVB-irradiated hairless mouse skin. Disruption of the skin barrier function after UVB irradiation as represented by the increase in transepidermal water loss (TEWL) was significantly suppressed with ISP-I treatment. In the ISP-Itreated skin, the peak of cell proliferation was observed 24 h earlier than in vehicle-treated skin. In addition, the number of apoptotic cells in ISP-I-treated skin showed a sharp decrease at 48 and 72 h post-irradiation. The number of stratum corneum cell layers was increased in ISP-I-treated skin at 72 h after UVB irradiation; at this time, TEWL in ISP-I-treated skin was lower than that in the vehicle-treated skin. We suggest ISP-I treatment altered cell proliferation and apoptosis after UVB exposure by modulating ceramide synthesis in epidermal cells, resulting in an increase of stratum corneum layers which lessened the effects of irradiation-induced barrier disruption. © 2010 Pharmaceutical Society of Japan.

Cite

CITATION STYLE

APA

Mizukoshi, K., Oshima, H., Matsumoto, K., Hirose, R., & Fujita, T. (2010). The effects of serine palmitoyltransferase inhibitor, ISP-I, on uv-induced barrier disruption in the stratum corneum. Biological and Pharmaceutical Bulletin, 33(12), 2008–2012. https://doi.org/10.1248/bpb.33.2008

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free